ID
45522
Descrizione
Principal Investigator: Javed Khan, MD, National Institutes of Health, Bethesda, MD, USA MeSH: Rhabdomyosarcoma,Rhabdomyosarcoma, Alveolar,Rhabdomyosarcoma, Embryonal https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000720 Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood accounting for approximately 350 newly diagnosed cases yearly in the United States. With the development of multimodal chemotherapy regimens, relapse-free survival rates have improved to 70-80% in patients with localized disease albeit with significant toxicity. Unfortunately, despite aggressive treatment, patients with metastatic or recurrent disease continue to suffer from high mortality. Further characterization of the genetic events underlying this tumor type is critical for the development of more effective diagnostic, prognostic and therapeutic strategies. In a collaborative effort between the National Cancer Institute, the Children's Oncology Group, and the Broad Institute, we use a combination of whole-genome and whole-exome sequencing to characterize the landscape of somatic alterations in 147 tumor/normal pairs.
collegamento
Keywords
versioni (2)
- 14/12/22 14/12/22 - Simon Heim
- 29/01/25 29/01/25 - Akane Nishihara
Titolare del copyright
Javed Khan, MD, National Institutes of Health, Bethesda, MD, USA
Caricato su
14 dicembre 2022
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
dbGaP phs000720 Genomic sequencing of Pediatric Rhabdomyosarcoma
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, sex, and consent group of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
- Subject ID, sample ID, and sample use variable of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
- Subject ID, age at onset, and sex of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
- Sample ID, body site where sample was obtained, analyte type, tumor status, histological type of sample, primary tumor or metastasis, and sequencing center of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, sex, and consent group of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
- Subject ID, sample ID, and sample use variable of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
- Subject ID, age at onset, and sex of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
- Sample ID, body site where sample was obtained, analyte type, tumor status, histological type of sample, primary tumor or metastasis, and sequencing center of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
C0680251 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C0441833 (UMLS CUI [1,4])
C1516477 (UMLS CUI [1,5])
C1513882 (UMLS CUI [1,6])
C4764268 (UMLS CUI [1,7])
Non ci sono commenti